Another study revealed that CDDO derivatives could provide neuroprotection against ischemic injury by upregulating heme oxygenase-1 (HO-1), suggesting that enhancing HO-1 expression may be a legitimate strategy for the therapeutic intervention of stroke [9]. Here, HMOX1 is linked to stroke disorder.